Table 5. Relationship of post-COVID-19 symptoms with acute COVID-19 infection severity.
| Post-COVID-19 symptoms | Mild, N=116), n (%) | Moderate (N=40, n (%) | Severe N=71, n (%) | P-value | |
| Breathlessness | 69 (59.5) | 30 (75.0) | 65 (91.5) | <0.001 | |
| Cough | 53 (45.7) | 17 (42.5) | 39 (54.9) | 0.35 | |
| Fatigue | 42 (36.2) | 25 (62.5) | 29 (40.8) | 0.01 | |
| Chest pain | 15 (12.9) | 6 (15.0) | 12 (16.9) | 0.75 | |
| Myalgia | 13 (11.2) | 9 (22.5) | 6 (8.5) | 0.11 | |
| Hemoptysis | 11 (9.5) | 5 (12.5) | 5 (7.0) | 0.61 | |
| Fever | 10 (8.6) | 4 (10.0) | 4 (5.6) | 0 .60 | |
| Hair loss | 7 (6.0) | 1 (2.5) | 4 (5.6) | 0.85 | |
| Palpitation | 4 (3.4) | 1 (2.5) | 3 (4.2) | 1.00 | |
| Sore throat | 4 (3.4) | 1 (2.5) | 1 (1.4) | 0.85 | |
| Loss of smell | 3 (2.6) | 1 (2.5) | 2 (2.8) | 1.00 | |
| Sneezing | 4 (3.4) | 0 (0.0) | 1 (1.4) | 0.58 | |
| Headache | 3 (2.6) | 1 (2.5) | 0 (0.0) | 0.39 | |
| Sleep disturbances | 3 (2.6) | 0 (0.0) | 0 (0.0) | 0.29 | |